A carregar...

Endogenous glucagon‐like peptide 1 controls endocrine pancreatic secretion and antro‐pyloro‐duodenal motility in humans

BACKGROUND: Exogenous use of the intestinal hormone glucagon‐like peptide 1 (GLP‐1) lowers glycaemia by stimulation of insulin, inhibition of glucagon, and delay of gastric emptying. AIMS: To assess the effects of endogenous GLP‐1 on endocrine pancreatic secretion and antro‐pyloro‐duodenal motility...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schirra, J, Nicolaus, M, Roggel, R, Katschinski, M, Storr, M, Woerle, H J, Göke, B
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2006
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1856508/
https://ncbi.nlm.nih.gov/pubmed/15985560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2004.059741
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!